After three years of corporate deadlock, the Delfin succession resolution could release a wave of strategic decisions across one of Europe's largest holding empires. The companies tied to this moment could move fast when the doors finally open.
Unified leadership at Delfin is widely expected to restart long-delayed dividend distributions across its portfolio. For income-focused investors, this could be a significant moment to watch closely.
From Italian banks to global luxury brands, professional analysts have flagged these assets as directly linked to the Delfin catalyst. When institutional money starts moving, the window for early positioning can close quickly.
This basket's market capitalisation is $1.00T and is dominated by large-cap stocks that anchor its weight, implying generally lower volatility and a more stable profile.
HSBC: $293.33B
UBS: $146.03B
DB: $62.04B
For years, a family succession dispute inside the Delfin holding company had frozen billions of euros in strategic decisions. Now, with a resolution in sight, unified leadership could unlock delayed dividends, trigger mergers and acquisitions, and reignite growth across a €56 billion portfolio spanning global eyewear, banking, and insurance.
This is a catalyst-driven theme — meaning it is built around a specific event that could shift the fortunes of several major European companies at once. It covers two key sectors: luxury consumer goods and European financial institutions. Both areas are closely tied to the strategic decisions that a newly empowered Delfin leadership could make.
These stocks were hand-picked by professional analysts to give broad exposure to the companies most likely to benefit from the Delfin consolidation. From Italian banks and global wealth managers to luxury eyewear and high-end fashion brands, each asset was selected for its direct or indirect link to this pivotal moment in European corporate history.
The resolution of a multibillion-euro succession battle within the Delfin holding company is set to break a three-year governance deadlock. This unified control could unleash new strategic momentum for major European assets, including EssilorLuxottica and key Italian financial institutions.
Get the full story on this Basket. Read our detailed article on its risks and potential.
Read Full Insight
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Part of Exinity Group 2015, serving over a million customers globally.
Earn 6% AER on uninvested cash with daily interest payments.
Published on March 6
Gilead Sciences has secured FDA approval for a new once-daily HIV combination pill, streamlining therapy for millions of suppressed patients. This regulatory milestone spotlights investment opportunities in pioneering biopharmaceutical companies and drug delivery developers focused on advanced antiviral treatments.
Disney is suing the FCC to block an early license review of its ABC stations, arguing the move is politically motivated retaliation against its news coverage. This unprecedented legal battle highlights the growing regulatory risks for traditional broadcasters and underscores the structural advantages of unregulated digital streaming platforms.
SK Hynix has unveiled a record-breaking 40 trillion won share buyback fueled by soaring demand for its AI memory chips. This historic capital return creates a compelling investment theme centered on high-bandwidth memory producers and the specialized equipment manufacturers that enable their advanced production.
+4
Here are a few of the assets in this group. Create an account to unlock the full list.
10 of 14 assets in this group are rated Buy by professional analysts.
